VAERS reports by lot

Pfizer COVID-19 lot HG7557: VAERS reports

106 VAERS reports list lot HG7557 as a Pfizer COVID-19 vaccine, received between 2023-11-14 and 2024-11-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
106
Reports
7%
Marked serious
3
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3124%
Cardiac / Cardiovascular1814%
Respiratory1814%
Neurological1512%
Gastrointestinal1310%
Musculoskeletal129%
Injection-site / Local reaction86%
Dermatological (non-injection-site)65%
Thrombotic / Hematological54%
Allergic / Anaphylactic32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Vermont19
Texas18
California9
Washington7
Michigan5
Virginia5
Idaho4
Ohio3
Minnesota3
North Carolina3
New York2
Oklahoma2

Reports by month received

2023-1120
2023-1213
2024-0119
2024-0213
2024-034
2024-0421
2024-054
2024-063
2024-081
2024-097
2024-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.